PAR 730 (Aspirin and Extended-Release Dipyridamole 25 mg / 200 mg)
Pill with imprint PAR 730 is Red & White, Capsule-shape and has been identified as Aspirin and Extended-Release Dipyridamole 25 mg / 200 mg. It is supplied by Par Pharmaceutical, Inc.
Aspirin/dipyridamole is used in the treatment of ischemic stroke, prophylaxis and belongs to the drug class platelet aggregation inhibitors. There is positive evidence of human fetal risk during pregnancy. Aspirin/dipyridamole 25 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PAR 730

Aspirin and Extended-Release Dipyridamole
- Imprint
- PAR 730
- Strength
- 25 mg / 200 mg
- Color
- Red & White
- Size
- 24.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Platelet aggregation inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical, Inc.
- National Drug Code (NDC)
- 49884-0007
- Inactive Ingredients
-
lactose anhydrous,
alginic acid,
corn starch,
stearic acid,
povidone,
triacetin,
magnesium silicate,
tartaric acid,
acacia,
gelatin,
sodium lauryl sulfate,
titanium dioxide,
FD&C Red No. 40,
FD&C Yellow No. 6,
potassium hydroxide,
xanthan gum,
shellac,
hypromelloses,
ferric oxide red,
ferric oxide yellow,
water,
ethylcellulose,
silicon dioxide,
ferrosoferric oxide
Note: Inactive ingredients may vary.
More about aspirin / dipyridamole
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (17)
- Drug images
- Pricing & coupons
- En español
- Drug class: platelet aggregation inhibitors
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.